Biogen (BIIB) Financials
Biogen (BIIB) Historical Financial Statements and Key Metrics for 1985 - 2023
Full Biogen financials for 1985 - 2023 are available in the
US Historical Financials dataset
All financial data is sourced direct from SEC 10-Q and 10-K filings, restatements are included.
Biogen Income Statements
(in $ 000,000's)
Quarter End | Revenue | Gross Profit | Operating Income | Net Income | EBITDA | EPS |
2023-Dec-31 | 2,386 | 1,768 (74.1 %) | 292 (12.2 %) | 250 (10.5 %) | 623 | 1.71 |
2023-Sep-30 | 2,530 | 1,871 (73.9 %) | -141 (-5.6 %) | -68 (-2.7 %) | 372 | -0.47 |
2023-Jun-30 | 2,456 | 1,863 (75.9 %) | 656 (26.7 %) | 592 (24.1 %) | 709 | 4.07 |
2023-Mar-31 | 2,463 | 1,800 (73.1 %) | 527 (21.4 %) | 388 (15.7 %) | 577 | 2.67 |
2022-Dec-31 | 2,544 | 1,973 (77.6 %) | 604 (23.7 %) | 550 (21.6 %) | 724 | 3.80 |
2022-Sep-30 | 2,508 | 2,039 (81.3 %) | 825 (32.9 %) | 1,135 (45.2 %) | 1,552 | 7.84 |
2022-Jun-30 | 2,589 | 2,105 (81.3 %) | 907 (35.0 %) | 1,058 (40.9 %) | 1,475 | 7.24 |
Full historical income statements for 1985 - 2023 is included in the
US Historical Financials dataset.
Biogen Balance Sheets
(in $ 000,000's)
Quarter End | Total Assets | Total Liabilities | Total Debt | Total Equity | Cash & Equivalents |
2023-Dec-31 | 26,845 | 12,045 | 7,338 | 14,799 | 1,050 |
2023-Sep-30 | 28,193 | 13,714 | 7,715 | 14,480 | 2,288 |
2023-Jun-30 | 25,157 | 10,696 | 6,589 | 14,460 | 6,078 |
2023-Mar-31 | 24,598 | 10,811 | 6,610 | 13,787 | 5,041 |
2022-Dec-31 | 24,554 | 10,222 | 6,614 | 13,398 | 4,893 |
2022-Sep-30 | 24,854 | 12,087 | 6,634 | 12,776 | 4,911 |
2022-Jun-30 | 25,081 | 13,218 | 7,551 | 11,872 | 4,798 |
Full historical balance sheet data for 1985 - 2023 is included in the
US Historical Financials dataset.
Biogen Cash Flow Statements
(in $ 000,000's)
Quarter End | Operating Cash Flow | Investing | Financing | Free Cash Flow |
2023-Dec-31 | 12 | -652 | -646 | -53 |
2023-Sep-30 | 592 | -1,742 | 849 | 505 |
2023-Jun-30 | 487 | -754 | -10 | 400 |
2023-Mar-31 | 455 | -953 | -43 | 384 |
2022-Dec-31 | -175 | -141 | -7 | -89 |
2022-Sep-30 | 661 | 1,672 | -1,252 | 602 |
2022-Jun-30 | 736 | 694 | -472 | 698 |
Full historical cash flow data for 1985 - 2023 is included in the
US Historical Financials dataset.
Biogen Key Valuation and Operating Metrics
Quarter End | Market Capitalization ($ 000,000's) |
Enterprise Value ($ 000,000's) |
Price/Earnings ($ 000,000's) |
Price/Sales ($ 000,000's) |
Price/Book ($ 000,000's) |
2023-Dec-31 | 37,496 | 43,784 | 15.71 | 37.54 | 2.53 |
2023-Sep-30 | 37,215 | 42,642 | 14.71 | -136.62 | 2.57 |
2023-Jun-30 | 41,218 | 45,189 | 16.78 | 17.42 | 2.85 |
2023-Mar-31 | 40,148 | 43,859 | 16.30 | 25.87 | 2.91 |
2022-Dec-31 | 39,987 | 43,182 | 15.72 | 18.16 | 2.98 |
2022-Sep-30 | 38,555 | 41,513 | 15.37 | 8.49 | 3.02 |
2022-Jun-30 | 29,755 | 34,660 | 11.49 | 7.03 | 2.51 |
Full historical valuation and operating metrics for 1985 - 2023 are included in the
US Historical Financials dataset.